As of 2025-12-25, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (15.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -975.3%.
The range of the Relative Valuation is (15.58) - (16.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 17.6x | 17.0x |
| Forward P/E multiples | 15.7x - 17.6x | 16.6x |
| Fair Price | (15.58) - (16.62) | (15.93) |
| Upside | -956.0% - -1013.2% | -975.3% |
| Date | P/E |